Navegar por autor "Campos Pérez, Francisco"

A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA)

2012- Leira Muiño, Rogelio Manuel; Sobrino Moreiras, Tomas; Blanco González, Miguel; Campos Pérez, Francisco; Rodríguez Yáñez, Manuel; [et al.]

Adult Stem Cells and Induced Pluripotent Stem Cells for Stroke Treatment

2019- Fernández Susavila, Héctor; Bugallo Casal, Ana Isabel; Castillo Sánchez, José; Campos Pérez, Francisco

Antihyperthermic treatment decreases perihematomal hypodensity

2020- Hervella ., Pablo; Rodríguez Yáñez, Manuel; Pumar Cebreiro, José Manuel; Ávila Gómez, Paulo; Da Silva Candal, Andrés Alexander; [et al.]

Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study

2020- Sobrino Moreiras, Tomas; Rodríguez Yáñez, Manuel; Campos Pérez, Francisco; Iglesias Rey, Ramón; Millán, Mónica; [et al.]

Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

2022- Ávila-Gómez, P.; Pérez Mato, María; Hervella Lorenzo, Pablo; Dopico López, Antonio; Da Silva Candal, Andrés Alexander; [et al.]

Blood glutamate EAAT(2)-cell grabbing therapy in cerebral ischemia

2019- Pérez Mato, María; Iglesias Rey, Ramón; Vieites Prado, Alba; Dopico López, Antonio; Argibay González, Bárbara; [et al.]

Blood glutamate grabbing does not reduce the hematoma in an intracerebral hemorrhage model but it is a safe excitotoxic treatment modality

2015- Sobrino Moreiras, Tomas; Campos Pérez, Francisco; Castillo Sánchez, José; Argibay González, Bárbara; Vieites Prado, Alba; [et al.]

Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels.

2011- Sobrino Moreiras, Tomas; Blanco González, Miguel; Campos Pérez, Francisco; Rodríguez Yáñez, Manuel; Castillo Sánchez, José; [et al.]

Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease

2014- Bueno, C.; Roldan, M.; Anguita, E.; Romero-Moya, D.; Martín-Antonio, B.; [et al.]

Clinical significance of the presence of endothelin-1 gene rs1800541 and rs5370 SNPs in patients with acute ischemic stroke

2011- Leira Muiño, Rogelio Manuel; Sobrino Moreiras, Tomas; Blanco González, Miguel; Campos Pérez, Francisco; Rodríguez Yáñez, Manuel; [et al.]

CM352, a new antifibrinolytic, reduces hematoma growth and improves functional recovery in a collagenase-induced rat model of intracerebral hemorrhage

2015- Sobrino Moreiras, Tomas; Campos Pérez, Francisco; Castillo Sánchez, José

Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome

2020- Ávila Gómez, Paulo; Vieites Prado, Alba; Dopico López, Antonio; Bashir, S.; Fernández Susavila, Héctor; [et al.]

Comparative analysis of systemic hypothermia and focal brain hypothermia in an animal model of cerebral ischemia

2015- Sobrino Moreiras, Tomas; Campos Pérez, Francisco; Castillo Sánchez, José; Vieites Prado, Alba

Evaluation of glutamate role in the effect of temperature on cerebral ischemia. An in vivo magnetic resonance spectroscopic analysis

2012- Campos Pérez, Francisco; Castillo Sánchez, José; Brea López, David; Pérez Mato, María; Ramos Cabrer, Pedro; [et al.]

Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model

2013- Campos Pérez, Francisco; Qin, T.; Castillo Sánchez, José; Seo, J. H.; Arai, K.; [et al.]

Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model

2013- Campos Pérez, Francisco; Castillo Sánchez, José

Genome-Wide Association Study of White Blood Cell Counts in Patients With Ischemic Stroke

2019- Torres-Aguila, N. P.; Carrera, C.; Giese, A. K.; Cullell, N.; Muino, E.; [et al.]

Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

2012- Campos Pérez, Francisco; Pérez Mato, María; Agulla Freire, Jesús; Blanco González, Miguel; Barral Raña, David; [et al.]

Glutamate neurotoxicity is involved in the neurological damage in patients undergoing extracorporeal circulation

2014- Álvarez Escudero, Julián; Sobrino Moreiras, Tomas; Blanco González, Miguel; Campos Pérez, Francisco; Castillo Sánchez, José; [et al.]

Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients

2013- Leira Muiño, Rogelio Manuel; Sobrino Moreiras, Tomas; Blanco González, Miguel; Campos Pérez, Francisco; Castillo Sánchez, José; [et al.]

Repositorio digital RUNA

Navegar por autor "Campos Pérez, Francisco"

A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA) ﻿

Adult Stem Cells and Induced Pluripotent Stem Cells for Stroke Treatment ﻿

Antihyperthermic treatment decreases perihematomal hypodensity ﻿

Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study ﻿

Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke ﻿

Blood glutamate EAAT(2)-cell grabbing therapy in cerebral ischemia ﻿

Blood glutamate grabbing does not reduce the hematoma in an intracerebral hemorrhage model but it is a safe excitotoxic treatment modality ﻿

Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels. ﻿

Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease ﻿

Clinical significance of the presence of endothelin-1 gene rs1800541 and rs5370 SNPs in patients with acute ischemic stroke ﻿

CM352, a new antifibrinolytic, reduces hematoma growth and improves functional recovery in a collagenase-induced rat model of intracerebral hemorrhage ﻿

Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome ﻿

Comparative analysis of systemic hypothermia and focal brain hypothermia in an animal model of cerebral ischemia ﻿

Evaluation of glutamate role in the effect of temperature on cerebral ischemia. An in vivo magnetic resonance spectroscopic analysis ﻿

Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model ﻿

Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model ﻿

Genome-Wide Association Study of White Blood Cell Counts in Patients With Ischemic Stroke ﻿

Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke ﻿

Glutamate neurotoxicity is involved in the neurological damage in patients undergoing extracorporeal circulation ﻿

Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients ﻿

A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA)

Adult Stem Cells and Induced Pluripotent Stem Cells for Stroke Treatment

Antihyperthermic treatment decreases perihematomal hypodensity

Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study

Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

Blood glutamate EAAT(2)-cell grabbing therapy in cerebral ischemia

Blood glutamate grabbing does not reduce the hematoma in an intracerebral hemorrhage model but it is a safe excitotoxic treatment modality

Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels.

Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease

Clinical significance of the presence of endothelin-1 gene rs1800541 and rs5370 SNPs in patients with acute ischemic stroke

CM352, a new antifibrinolytic, reduces hematoma growth and improves functional recovery in a collagenase-induced rat model of intracerebral hemorrhage

Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome

Comparative analysis of systemic hypothermia and focal brain hypothermia in an animal model of cerebral ischemia

Evaluation of glutamate role in the effect of temperature on cerebral ischemia. An in vivo magnetic resonance spectroscopic analysis

Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model

Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model

Genome-Wide Association Study of White Blood Cell Counts in Patients With Ischemic Stroke

Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

Glutamate neurotoxicity is involved in the neurological damage in patients undergoing extracorporeal circulation

Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients